Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Gliosarcoma 131Glioblastoma 128Central Nervous System Neoplasms 58Glioma 51Brain Neoplasms 48Astrocytoma 45Oligodendroglioma 32Sarcoma 23Sarcoma, Ewing 22Rhabdomyosarcoma 18Neuroblastoma 14Medulloblastoma 14Ependymoma 14Osteosarcoma 10Neoplasms 6Choroid Plexus Neoplasms 6Wilms Tumor 5Recurrence 5Ovarian Neoplasms 5Neuroectodermal Tumors, Primitive, Peripheral 5Glioma, Subependymal 5Familial ependymoma 5Rhabdoid Tumor 4Pinealoma 4Optic Nerve Glioma 4Neuroectodermal Tumors, Primitive 4Leiomyosarcoma 4Diffuse Intrinsic Pontine Glioma 4Testicular Neoplasms 3Kidney Neoplasms 3

Interventions

Temozolomide 1Radiotherapy 1Radiation 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Diseases × Temozolomide × Sarcoma × Clear all
NCT00895960 2018-11-08

Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma

M.D. Anderson Cancer Center

Phase 1 Terminated
16 enrolled
CNSSarcoma

Brain Diseases, Central Nervous System Diseases, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡